Corpus Intelligence IC Memo — MCLAREN PORT HURON 2026-04-26 04:03 UTC
IC Memo — MCLAREN PORT HURON
Investment Committee Memorandum | MI | 163 beds | Grade C | EBITDA uplift $16.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MCLAREN PORT HURON

CCN 230216 | ST. CLAIR, MI | 163 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MCLAREN PORT HURON is a 163-bed suburban community hospital in ST. CLAIR, MI with $225.7M in net patient revenue and a -0.2% operating margin. The hospital serves a payer mix of 29.9% Medicare, 5.2% Medicaid, and 64.9% commercial.

Thesis: Undervalued. Our ML models identify $16.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.2% to 7.2% (+736bps).

Net Revenue HCRIS$225.7M
Current EBITDA COMPUTED$-395K
Operating Margin COMPUTED-0.2%
Occupancy HCRIS70.8%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS30.8%
Distress Probability ML43.7%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
53
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -0.2% places it above the state median. Among 53 size-comparable peers (82-326 beds), the median margin is -6.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (82-326), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MCLAREN PORT HURON (Target)MI163$225.7M-0.2%
TRINITY HEALTH MUSKEGONMI262$621.2M-15.5%
TRINITY HEALTH GRAND RAPIDSMI271$601.8M-27.3%
HENRY FORD HEALTH MACOMB HOSPIMI303$584.5M-6.9%
MYMICHIGAN MEDICAL CENTER MIDLMI195$537.8M-9.6%
METROPOLITAN HOSPITALMI201$512.0M-11.3%
LAKELAND MEDICAL CENTER ST. JMI235$488.2M-3.6%
HENRY FORD WEST BLOOMFIELD HOSMI191$446.0M5.5%
MCLAREN FLINTMI276$443.4M-1.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.7M+210bp18mo
Cost to Collect4.5%2.5%$4.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.7M+122bp9mo
Clean Claim Rate88.0%96.0%$144K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.7M
Cost to Collect
$4.5M
Denial Rate Reduction
$4.5M
A/R Days Reduction
$2.7M
Clean Claim Rate
$144K
Total EBITDA Uplift$16.6M
Current EBITDA$-395K
+ RCM Uplift+$16.6M
Pro Forma EBITDA$16.2M
Current Margin-0.2%
Pro Forma Margin7.2%
WC Released (1x)$8.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-608K$163.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-608K$179.7M0.00x-100.0%
Bull Case9.0x11.0x$-547K$234.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-547K$255.4M0.00x-100.0%
Bear Case11.0x10.0x$-669K$80.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-669K$88.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 82-326 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-13.5% / P50=-6.8% / P75=-0.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.